Influenza C virus in pre-school children with respiratory infections: retrospective analysis of data from the national influenza surveillance system in Germany, 2012 to 2014.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Mar 2019
Historique:
entrez: 14 3 2019
pubmed: 14 3 2019
medline: 9 7 2020
Statut: ppublish

Résumé

IntroductionRecent data on influenza C virus indicate a possible higher clinical impact in specified patient populations than previously thought.AimWe aimed to investigate influenza C virus circulation in Germany.MethodsA total of 1,588 samples from 0 to 4 year-old children presenting as outpatients with influenza-like illness (ILI) or acute respiratory infection were analysed retrospectively. The samples represented a subset of all samples from the German national surveillance system for influenza in this age group in 2012-14. The presence of influenza C virus was investigated by real-time PCR. For positive samples, information on symptoms as well as other respiratory virus co-infections was considered. Retrieved influenza C viral sequences were phylogenetically characterised.ResultsInfluenza C viral RNA was detected in 20 (1.3% of) samples, including 16 during the 2012/13 season. The majority (18/20) of influenza C-positive patients had ILI according to the European Union definition, one patient had pneumonia. Viruses belonged to the C/Sao Paulo and C/Kanagawa lineages. Most (11/20) samples were co-infected with other respiratory viruses.ConclusionOur data are the first on influenza C virus circulation in Germany and notably from a European national surveillance system. The low detection frequency and the identified virus variants confirm earlier observations outside a surveillance system. More virus detections during the 2012/13 season indicate a variable circulation intensity in the different years studied. Influenza C virus can be considered for ILI patients. Future studies addressing its clinical impact, especially in patients with severe disease are needed.

Identifiants

pubmed: 30862333
doi: 10.2807/1560-7917.ES.2019.24.10.1800174
pmc: PMC6415498
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Infect Dis. 2001 Apr 15;183(8):1269-72
pubmed: 11262210
J Infect. 1992 Jan;24(1):91-9
pubmed: 1312564
J Infect Dis. 2006 May 1;193(9):1229-35
pubmed: 16586359
J Med Virol. 2008 Aug;80(8):1441-6
pubmed: 18551600
J Clin Microbiol. 2009 Jun;47(6):1800-10
pubmed: 19386848
J Pediatr. 1991 Feb;118(2):235-8
pubmed: 1993950
PLoS One. 2010 Apr 01;5(4):e9966
pubmed: 20376359
Diagn Microbiol Infect Dis. 2011 Apr;69(4):419-27
pubmed: 21396539
J Trop Med. 2011;2011:690286
pubmed: 22007241
J Clin Virol. 2012 Jun;54(2):130-4
pubmed: 22398038
Influenza Other Respir Viruses. 2013 Nov;7(6):954-60
pubmed: 23445084
Influenza Other Respir Viruses. 2013 Nov;7(6):999-1003
pubmed: 23594251
Pediatr Infect Dis J. 2013 Aug;32(8):916-9
pubmed: 23624431
J Med Virol. 2014 May;86(5):879-85
pubmed: 24122799
PLoS One. 2014 Feb 05;9(2):e88342
pubmed: 24505479
Methods Mol Biol. 2014;1160:5-17
pubmed: 24740217
J Clin Virol. 2014 Sep;61(1):87-93
pubmed: 25017953
J Clin Microbiol. 2015 Mar;53(3):847-58
pubmed: 25552361
Protein Cell. 2016 Jan;7(1):28-45
pubmed: 26215728
Pediatr Infect Dis J. 2015 Nov;34(11):1273-5
pubmed: 26244834
J Clin Virol. 2016 Jan;74:50-3
pubmed: 26655269
Influenza Other Respir Viruses. 2016 Nov;10(6):455-461
pubmed: 27373693
J Virol. 2016 Aug 26;90(18):8251-65
pubmed: 27384661
Viruses. 2016 Nov 26;8(12):
pubmed: 27898037
Sci Rep. 2017 Apr 13;7:46578
pubmed: 28406194
Clin Infect Dis. 2017 Sep 15;65(6):1037-1039
pubmed: 28541414
J Clin Virol. 2017 Nov;96:12-16
pubmed: 28917132
J Virol. 1979 Dec;32(3):1006-14
pubmed: 513198
Br Med J. 1968 Oct 19;4(5624):153-4
pubmed: 5681050
J Virol. 1984 Apr;50(1):118-24
pubmed: 6699942
Microbiol Immunol. 1982;26(7):639-42
pubmed: 7132793

Auteurs

Annemarie Fritsch (A)

Robert Koch Institute, National Reference Center for Influenza, FG 17 Influenza and Other Respiratory Viruses, Berlin, Germany.

Brunhilde Schweiger (B)

Robert Koch Institute, National Reference Center for Influenza, FG 17 Influenza and Other Respiratory Viruses, Berlin, Germany.

Barbara Biere (B)

Robert Koch Institute, National Reference Center for Influenza, FG 17 Influenza and Other Respiratory Viruses, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH